Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. (Q39747942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

multiple drug resistance

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

K Tajima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R Ohashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Y Sekido

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T Hida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T Nara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Iwakami

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Minakata

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T Yae

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

F Takahashi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Saya

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Takahashi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

18 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1941-1951

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2009.478

17 January 2020

exact match

0 references

cites work

Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Integrins and extracellular matrix: a novel mechanism of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Hyaluronan production increases the malignant properties of mesothelioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Osteopontin: role in cell signaling and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Prognostic factors of malignant mesothelioma of the pleura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Asbestos exposure, pleural mesothelioma, and serum osteopontin levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Osteopontin induces angiogenesis of murine neuroblastoma cells in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

Immunohistochemical differences between hyaluronan- and non-hyaluronan-producing malignant mesothelioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.478

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20101228%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference